Leukaemia & Blood Cancers
This session focuses
on the clinical management and molecular underpinnings of haematologic malignancies
including leukaemia, lymphoma, and multiple myeloma. Discussions will cover
diagnostic innovations, risk stratification, and evolving therapeutic
strategies, such as targeted agents and immunotherapies.
Case studies will
illustrate management of minimal residual disease and treatment-resistant
cases. Stem cell
transplantation and cellular therapies will be explored as curative options in
specific settings. The session will review recent guidelines and clinical trial
outcomes.
Subtracks:
- Acute and Chronic Leukaemia Management
- Lymphoma Therapeutic Strategies
- Multiple Myeloma Updates
- Minimal Residual Disease Monitoring
- Cellular Therapies in Haematologic Cancers
- Stem Cell Transplantation Innovations